Omeros Corporation (OMER)
NASDAQ: OMER
· Real-Time Price · USD
3.19
-0.13 (-3.92%)
At close: Jun 27, 2025, 3:59 PM
3.37
5.59%
After-hours: Jun 27, 2025, 06:18 PM EDT
-3.92% (1D)
| Bid | 3.12 |
| Market Cap | 186.91M |
| Revenue (ttm) | 412K |
| Net Income (ttm) | -153.09M |
| EPS (ttm) | -3.04 |
| PE Ratio (ttm) | -1.05 |
| Forward PE | -55.5 |
| Analyst | Buy |
| Ask | 3.65 |
| Volume | 789,963 |
| Avg. Volume (20D) | 1,029,495 |
| Open | 3.30 |
| Previous Close | 3.32 |
| Day's Range | 3.19 - 3.42 |
| 52-Week Range | 2.97 - 13.60 |
| Beta | 2.20 |
About OMER
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OMER
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OMER stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+3.89%
Omeros shares are trading after the company announ...
Unlock content with
Pro Subscription
6 months ago
+37.27%
Omeros shares are trading higher after the company announced that narsoplimab met its primary trial endpoint and will resubmit its narsoplimab Biologics License Application to the FDA.
